推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

CANCER SCIENCE 期刊收藏夹

2026年3月最新《新锐期刊分区表》数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
近期推荐:
全流程投稿协助套餐服务
SCI论文AI润色+人工QC服务
Springer Nature特刊征稿
已发表SCI?是时候来Springer出书了!
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CANCER SCIENCE期刊基本信息Hello,您是该期刊的第64749位访客

基本信息 登录收藏
期刊名字CANCER SCIENCECANCER SCIENCE

CANCER SCI
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.6
50人评分
我要评分

声誉
8.3

影响力
6.6

速度
9.7

期刊ISSN1349-7006
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
P-ISSN1347-9032
2024-2025最新影响因子
(数据来源于搜索引擎)
4.3 点击查看影响因子趋势图
实时影响因子 截止2026年1月20日:4.7
2024-2025自引率2.3%点击查看自引率趋势图
五年影响因子5.1
JCI期刊引文指标 1.01
h-index 123
CiteScore
2025年最新版
CiteScoreSJRSNIPCiteScore排名
9.301.6611.040
学科分区排名百分位
大类:Medicine
小类:Oncology
Q160 / 415
大类:Medicine
小类:Cancer Research
Q153 / 233

期刊简介
Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports.

Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.
期刊官方网站http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291349-7006
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://mc.manuscriptcentral.com/cas
该期刊中国学者近期发文 - NewEpacadostat Overcomes Cetuximab Resistance in Colorectal Cancer by Targeting IDO-Mediated Tryptophan Metabolism
Author: Zhou, Yimin; Tao, Qiongyan; Luo, Chubin; Chen, Jinsong; Chen, Genwen; Sun, Jianyong
Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1715-1729. DOI: 10.1111/cas.70057


Risk Stratification Prediction of Endometrial Cancer Using Microstructural Mapping Based on Time-Dependent Diffusion MRI
Author: Zhao, Yu; Zhao, Feng; Cheng, Meng; Wang, Gang; Wang, Dan; Yin, Huijuan; Xue, Zhixiao; Chen, Yule; Zhao, Zhen; Ma, Hui; Zhang, Xiaoxiao; Wang, Junping; Li, Fengtan
Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1627-1637. DOI: 10.1111/cas.70036


Lnc-TPT1-AS1/CBP/ATIC Axis Mediated Purine Metabolism Activation Promotes Breast Cancer Progression
Author: Zhang, Yiyun; Zhang, Hanyu; Li, Mingcui; Li, Yanling; Wang, Zhuo-Ran; Cheng, Weilun; Liu, Yansong; Fang, Zhengbo; Zheng, Ang; Wang, Jingxuan; Ma, Fei
Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1565-1578. DOI: 10.1111/cas.70045


Spatial Heterogeneity of PD-L1 Expression as a Biomarker for Third-Generation EGFR-TKI Response in Advanced EGFR-Mutant NSCLC
Author: Zhang, Yidan; Xu, Yingqi; Jin, Hongping; Liu, Tengfei; Zhong, Hua; Xu, Jianlin; Lou, Yuqing; Zhong, Runbo
Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1648-1660. DOI: 10.1111/cas.70060


期刊语言要求Language
Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER SCIENCE的语言要求,还能让CANCER SCIENCE编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER SCIENCE编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(2篇)
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2600; GBP1650; EUR2350; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:oncology、cancer research、palliative care、radiotherapy
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774
出版商Wiley-Blackwell
涉及的研究方向ONCOLOGY-
出版国家或地区JAPAN
出版语言English
出版周期
出版年份0
年文章数 327点击查看年文章数趋势图
Gold OA文章占比96.48%
研究类文章占比:
文章 ÷(文章 + 综述)
87.16%
WOS期刊JCR分区
2024-2025年最新版
WOS分区等级:2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ288/328
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ179/328
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
2026年3月发布
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区3区
ONCOLOGY
肿瘤学
2区1区2区
N/A
期刊分区表
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区1区
ONCOLOGY
肿瘤学
1区1区3区
期刊分区表
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区1区
ONCOLOGY
肿瘤学
4区1区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
中科院的全球OA期刊索引(OAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1349-7006%5BISSN%5D
平均审稿速度网友分享经验:
17 Weeks
平均录用比例网友分享经验:
版面费/APC文章处理费信息
文章处理费:需要( USD2600; GBP1650; EUR2350; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CANCER SCIENCE顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(2篇)
提交文稿
期刊常用信息链接
同领域相关期刊 CANCER SCIENCE期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CANCER SCIENCE期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CANCER SCIENCE上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    ANNALS OF ONCOLOGY21070.40
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE864276
    JOURNAL OF ETHNOPHARMACOLOGY774319
    Frontiers in Immunology701486
    BIOMEDICINE & PHARMACOTHERAPY698079
    BIOMATERIALS692752
    Frontiers in Pharmacology679485
    PHYTOMEDICINE606217
    Frontiers in Oncology595829
    IEEE Journal of Biomedical and Health Informatics560600
    Biomedical Signal Processing and Control557353
  •  

    CANCER SCIENCE CANCER SCIENCE
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Epacadostat Overcomes Cetuximab Resistance in Colorectal Cancer by Targeting IDO-Mediated Tryptophan Metabolism

    Author: Zhou, Yimin; Tao, Qiongyan; Luo, Chubin; Chen, Jinsong; Chen, Genwen; Sun, Jianyong
    Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1715-1729. DOI: 10.1111/cas.70057
        PubMed      DOI
    2.Risk Stratification Prediction of Endometrial Cancer Using Microstructural Mapping Based on Time-Dependent Diffusion MRI

    Author: Zhao, Yu; Zhao, Feng; Cheng, Meng; Wang, Gang; Wang, Dan; Yin, Huijuan; Xue, Zhixiao; Chen, Yule; Zhao, Zhen; Ma, Hui; Zhang, Xiaoxiao; Wang, Junping; Li, Fengtan
    Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1627-1637. DOI: 10.1111/cas.70036
        PubMed      DOI
    3.Lnc-TPT1-AS1/CBP/ATIC Axis Mediated Purine Metabolism Activation Promotes Breast Cancer Progression

    Author: Zhang, Yiyun; Zhang, Hanyu; Li, Mingcui; Li, Yanling; Wang, Zhuo-Ran; Cheng, Weilun; Liu, Yansong; Fang, Zhengbo; Zheng, Ang; Wang, Jingxuan; Ma, Fei
    Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1565-1578. DOI: 10.1111/cas.70045
        PubMed      DOI
    4.Spatial Heterogeneity of PD-L1 Expression as a Biomarker for Third-Generation EGFR-TKI Response in Advanced EGFR-Mutant NSCLC

    Author: Zhang, Yidan; Xu, Yingqi; Jin, Hongping; Liu, Tengfei; Zhong, Hua; Xu, Jianlin; Lou, Yuqing; Zhong, Runbo
    Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1648-1660. DOI: 10.1111/cas.70060
        PubMed      DOI
    5.VCP Promotes Cholangiocarcinoma Development by Mediating BAP1 Ubiquitination-Dependent Degradation

    Author: Zhang, Peiying; Liu, Xiangning; Liu, Yue; Zhu, Hongdao; Zheng, Churun; Ling, Qi; Yan, Fangjie; He, Qiaojun; Zhu, Hong; Yuan, Tao; Yang, Bo
    Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1579-1591. DOI: 10.1111/cas.70061
        PubMed      DOI
    6.GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A

    Author: Zhang, Hui-min; Li, Han-ning; Qi, Enbo; Yang, Yang; Ma, Huiping; Ma, Jie; Xiong, Xiwen; Wang, Jun; Yang, Zhi-fang; Liao, Xing-hua
    Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1592-1603. DOI: 10.1111/cas.70039
        PubMed      DOI
    7.Exosomal PKM2: A Noninvasive Diagnostic Marker Linking Macrophage Metabolic Reprogramming to Gastric Cancer Pathogenesis

    Author: Yuan, Mengyun; Zheng, Xiaoxia; Zheng, Shanshan; Li, Huaizhi; Zhang, Xingxing; Chen, Yuxuan; Zhang, Xiang; Han, Bo; Wei, Wei; Wu, Jian; Sun, Qingmin
    Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1537-1549. DOI: 10.1111/cas.70056
        PubMed      DOI
    8.Induction Camrelizumab and Modified TPF (Nab-Paclitaxel, Cisplatin, and S-1) in Locoregionally Advanced Nasopharyngeal Carcinoma

    Author: Yu, Yi-Feng; Dai, Ya-Qing; Zhang, Zong-Kai; Lu, Guan-Zhong; Lin, Qin; Wu, San-Gang
    Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1616-1626. DOI: 10.1111/cas.70037
        PubMed      DOI
    9.STAB1 Promotes Acute Myeloid Leukemia Progression by Activating the IKK/NF-κB Pathway and Increasing M2 Macrophage Polarization

    Author: Yin, Jiaxiu; Luo, Jing; Wang, Lan; Liu, Lanxiang; Liu, Lin
    Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1508-1521. DOI: 10.1111/cas.70044
        PubMed      DOI
    10.LTF as a Potential Predictive Biomarker for Durable Benefit From First-Line Chemo-Immunotherapy in Small Cell Lung Cancer

    Author: Shen, Shimo; Wu, Yili; Shao, Zhuowei; Li, You; Peng, Di; Li, Bing; Zhang, Zhou; Wu, Shibo
    Journal: CANCER SCIENCE. 2025; Vol. 116, Issue 6, pp. 1522-1536. DOI: 10.1111/cas.70049
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    ANNALS OF ONCOLOGY21070.40
    同分区等级的其他期刊名称 h-index CiteScore
    MMWR Surveillance Summaries081.80
    NEW ASTRONOMY REVIEWS5221.50
    Computational Visual Media028.50
    Journal of the National Comprehensive Cancer Network8824.70
    International Journal of Transgender Health013.20
    ENDOCRINE PATHOLOGY4217.40
    HemaSphere07.20
    IEEE Transactions on Intelligent Vehicles017.00
    BEHAVIORAL AND BRAIN SCIENCES1482.20
    CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE10222.40
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共702


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室